CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-10 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,340 | $1.53 | $4K | 76,540 |
| 2021-03-10 | Virgin Herbert EVP, Research & CSO | Sale | −2,340 | $48.00 | $112K | 74,200 |
| 2021-03-10 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,340 | 345,455 | ||
| 2021-03-09 | Virgin Herbert EVP, Research & CSO | Option exercise | +5,560 | $1.53 | $9K | 79,760 |
| 2021-03-09 | Virgin Herbert EVP, Research & CSO | Sale | −5,560 | $44.80 | $249K | 74,200 |
| 2021-03-09 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −5,560 | 347,795 | ||
| 2021-03-01 | Parrish Jay Chief Business Officer | Option exercise | +4,630 | $1.49 | $7K | 13,890 |
| 2021-03-01 | Parrish Jay Chief Business Officer | Option exercise | +2,314 | $1.58 | $4K | 16,204 |
| 2021-03-01 | Parrish Jay Chief Business Officer | Sale | −6,944 | $63.44 | $441K | 9,260 |
| 2021-03-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −4,630 | 9,259 | ||
| 2021-03-01 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −2,314 | 39,352 | ||
| 2021-02-23 | Virgin Herbert EVP, Research & CSO | Option exercise | +18,900 | $1.53 | $29K | 82,100 |
| 2021-02-23 | Virgin Herbert EVP, Research & CSO | Sale | −7,900 | $63.74 | $504K | 74,200 |
| 2021-02-23 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −18,900 | 353,355 | ||
| 2021-02-16 | Pang Phillip Chief Medical Officer | Option exercise | +10,000 | $0.86 | $9K | 77,277 |
| 2021-02-16 | Pang Phillip Chief Medical Officer | Grant or award | +32,000 | 109,277 | ||
| 2021-02-16 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 33,833 | ||
| 2021-02-16 | Pang Phillip Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +64,000 | 64,000 | ||
| 2021-02-16 | Horn Howard CFO | Grant or award | +25,000 | 202,777 | ||
| 2021-02-16 | Horn Howard CFO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 45 of 54 · 1,063 trades